Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 6/20 | 0.71 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.71 |
| ▸ | OPRK1 | P41145 | 4/20 | 0.71 |
| ▸ | DRD3 | P35462 | 3/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.55 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.55 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | DRD2 | P14416 | 1/20 | 0.47 |
| ▸ | DRD4 | P21917 | 1/20 | 0.47 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.43 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.42 |
| ▸ | SCN1A | P35498 | 1/20 | 0.42 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.42 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3321232 | 0.99 | OPRM1 (0.70) | OPRM1OPRD1OPRK1DRD3LMNA | |
| SCHEMBL28398971 | 0.88 | OPRM1 (0.65) | OPRM1OPRD1OPRK1DRD3LMNA | |
| SCHEMBL19475378 | 0.87 | DRD3 (0.68) | OPRM1OPRD1OPRK1DRD3LMNA | |
| SCHEMBL11458105 | 0.86 | DRD3 (0.67) | OPRM1OPRD1OPRK1DRD3LMNA | |
| Hydrochloric Acid SCHEMBL10969957 | 0.86 | OPRM1 (0.54) | OPRM1OPRD1OPRK1DRD3LMNA | |
| SCHEMBL19717856 | 0.83 | DRD3 (0.64) | OPRM1OPRD1OPRK1DRD3LMNA | |
| SCHEMBL22790441 | 0.83 | OPRM1 (0.60) | OPRM1OPRD1OPRK1DRD3LMNA | |
| SCHEMBL15734501 | 0.83 | DRD3 (0.70) | OPRM1OPRD1OPRK1DRD3LMNA | |
| SCHEMBL11196518 | 0.82 | OPRM1 (0.54) | OPRM1OPRD1OPRK1DRD3LMNA | |
| Hydrochloric Acid SCHEMBL11204271 | 0.81 | OPRM1 (0.53) | OPRM1OPRD1OPRK1DRD3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 397 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4049985-B1 | FILLER FOR WALL COATINGS | AMBERGER KAOLINWERKE EDUARD KICK GMBH & CO KG (DE) | 2026-04-01 | — | — | EP | claimed |
| CN-119903917-A | Multi-mode-based priori-posterior knowledge prompting and reasoning method | 大连大学 | 2025-04-29 | — | — | CN | claimed |
| US-20240343784-A1 | TREATMENT OF MEDICATION OVERUSE HEADACHE USING ANTI-CGRP OR ANTI-CGRP-R ANTIBODIES | H LUNDBECK AS (DK) | 2024-10-17 | — | — | US | claimed |
| US-12118110-B2 | Identity query language systems and methods | Strata Identity, Inc. (US) | 2024-10-15 | — | — | US | claimed |
| CN-118763735-A | Comprehensive energy system multi-time scale optimization scheduling strategy based on economic model predictive control | 华北电力大学 | 2024-10-11 | — | — | CN | claimed |
| US-20240288374-A1 | PLASMONIC NANOPARTICLE PLATFORM FOR ANALYTE DETECTION | Zymeron Corporation | 2024-08-29 | — | — | US | claimed |
| WO-2024172892-A1 | PLASMONIC NANOPARTICLE PLATFORM FOR ANALYTE DETECTION | Zymeron Corporation (US) | 2024-08-22 | — | — | WO | claimed |
| US-12065391-B2 | Composition containing N-(n-butyl) thiophosphoric triamide adducts and reaction products | KOCH AGRONOMIC SERVICES, LLC (US) | 2024-08-20 | — | — | US | claimed |
| EP-4168209-B1 | COMPUTER IMPLEMENTED METHOD OF AND OPTIMISATION TOOL FOR REFINEMENT OF LASER CUTTING PROCESS PARAMETERS BY MEANS OF AN OPTIMIZATION TOOL, WITH CORRESPONDING COMPUTER PROGRAM | BYSTRONIC LASER AG (CH) | 2024-06-05 | — | — | EP | claimed |
| US-20240083877-A1 | NOVEL SCAFFOLD OF ADENYLYL CYCLASE INHIBITORS FOR CHRONIC PAIN AND OPIOID DEPENDENCE | PURDUE RESEARCH FOUNDATION (US) | 2024-03-14 | — | — | US | claimed |
| CN-116005453-A | Preparation method and application process of natural fiber fabric flame retardant with water washing resistance, no aldehyde, no color change and no pungent odor | 深圳市尼森实业有限公司 | 2023-04-25 | — | — | CN | claimed |
| WO-2023019186-A2 | COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER | THE JOHNS HOPKINS UNIVERSITY (US) | 2023-02-16 | — | — | WO | claimed |
| WO-2022246104-A1 | ELECTROCHEMICAL SENSOR FOR THE MEASUREMENT OF GLUCOSE CONCENTRATION | ARKANSAS STATE UNIVERSTIY-JONESBORO (US) | 2022-11-24 | — | — | WO | claimed |
| US-20220318416-A1 | IDENTITY QUERY LANGUAGE SYSTEMS AND METHODS | WESTERN ALLIANCE BANK | 2022-10-06 | — | — | US | claimed |
| WO-2022212949-A1 | IDENTITY QUERY LANGUAGE SYSTEMS AND METHODS | Strata Identity, Inc. (US) | 2022-10-06 | — | — | WO | claimed |
| EP-3514183-B1 | PELLETIZED POLYMER COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-05-04 | — | — | EP | claimed |
| WO-2022058113-A1 | COMPUTER IMPLEMENTED METHOD OF AND OPTIMISATION TOOL FOR REFINEMENT OF LASER CUTTING PROCESS PARAMETERS BY MEANS OF AN OPTIMIZATION TOOL | BYSTRONIC LASER AG (CH) | 2022-03-24 | — | — | WO | claimed |
| EP-3970905-A1 | COMPUTER IMPLEMENTED METHOD OF AND OPTIMISATION TOOL FOR REFINEMENT OF LASER CUTTING PROCESS PARAMETERS BY MEANS OF AN OPTIMIZATION TOOL | Bystronic Laser AG (CH) | 2022-03-23 | — | — | EP | claimed |
| WO-2014153099-A2 | METHOD FOR USING EXHALED BREATH TO DETERMINE THE PRESENCE OF DRUG | Pulmonary Analytics (US) | 2014-09-25 | — | — | WO | claimed |
| US-20140288454-A1 | Method For Using Exhaled Breath to Determine the Presence of Drug | Pulmonary Analytics (US) | 2014-09-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240083877-A1 | NOVEL SCAFFOLD OF ADENYLYL CYCLASE INHIBITORS FOR CHRONIC PAIN AND OPIOID DEPENDENCE | CAP1, ADCY1, ADCYAP1R1 | OPRM1 28/4885OPRD1 14/4885OPRK1 11/4885 |
| US-12065391-B2 | Composition containing N-(n-butyl) thiophosphoric triamide adducts and reaction products | PNP, PFAS, MTAP | OPRM1 3976/4885OPRD1 4769/4885OPRK1 4797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.